Literature DB >> 9328264

Transitional progressive multiple sclerosis: a clinical and imaging study.

A Gayou1, B Brochet, V Dousset.   

Abstract

OBJECTIVE: To study the prevalence and the natural course of transitional progressive multiple sclerosis (TPMS). This clinical form is defined by a progressive course beginning many years after an isolated bout.
METHODS: 214 consecutive outpatients with definite or probable multiple sclerosis were studied. The prevalence of TPMS was established. Patients with TPMS were compared with patients with other progressive forms of multiple sclerosis according to the clinical course. A prospective one year follow up study was performed in a subgroup of patients to compare progression of the disease using clinical indices and MRI.
RESULTS: In this clinical population of 214 outpatients with multiple sclerosis, 55 had secondary progressive multiple sclerosis (SPMS), 38 primary progressive multiple sclerosis (PPMS), and 12 TPMS. Retrospective analysis of the clinical data of these patients shows that TPMS is very similar to SPMS at the beginning of the disease (age at onset, time before progression, clinical symptoms at onset, progression index). In addition a cohort of patients was prospectively followed up clinically and by MRI for one year.
CONCLUSIONS: The results did not show any significant differences between the three forms during this follow up. However, all data showed a concordant trend suggesting that at this progressive stage, TPMS is closer to PPMS in terms of progression of disability and new MRI lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9328264      PMCID: PMC2169693          DOI: 10.1136/jnnp.63.3.396

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

1.  European validation of a standardized clinical description of multiple sclerosis.

Authors:  Maria Pia Amato; Jerome Grimaud; Iuliana Achiti; Maria Letizia Bartolozzi; Patrice Adeleine; Hans-Peter Hartung; Ludwig Kappos; Alan Thompson; Maria Trojano; Sandra Vukusic; Christian Confavreux
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

Review 2.  Differentiation of multiple sclerosis subtypes: implications for treatment.

Authors:  Andreas Bitsch; Wolfgang Brück
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.

Authors:  Aurélie Ruet; Mathilde Deloire; Delphine Hamel; Jean-Christophe Ouallet; Klaus Petry; Bruno Brochet
Journal:  J Neurol       Date:  2012-10-19       Impact factor: 4.849

4.  One year follow up study of primary and transitional progressive multiple sclerosis.

Authors:  V L Stevenson; D H Miller; S M Leary; M Rovaris; F Barkhof; B Brochet; V Dousset; M Filippi; R Hintzen; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.